Bexleyheath Clinic 300 Broadway, Bexleyheath DA6 8AH
Disclosures: Liam Swain: Nothing to Disclose, Abdel Shaheen: Nothing to Disclose, Meng Wang: Nothing to Disclose, Jennifer Flemming: Nothing to Disclose, Mayur Brahmania: Nothing to Disclose, Juan Abraldes: Gilead: Grant/Research Support, 89bio: Consultant, Boston Pharmaceuticals: Consultant, Novo Nordisk: Consultant, Boehringer Ingelheim: Consultant, Astra Zeneca: Consultant, Agomab: Consultant, Terumo: Speaking and Teaching, Cook: Grant/Research Support, Karen Tang: Nothing to Disclose, Jenny Godley: Nothing to Disclose 1550 ENGINEERED HUMAN LIVER CO-CULTURES TO MODEL HEPATIC DYSFUNCTIONS IN METALD Owen Lally 1 , 1 University of Illinois Chicago Background: Metabolic dysfunction-associated liver disease (MASLD) with increased alcohol intake is characterized by symptoms of both MASLD and alcohol-associated liver disease (ALD), known as MetALD
It is widely used in neurological therapies due to its neuroprotective and neuroregenerative properties
Fortunately, several factors act to narrow the structural options, and it is possible to identify some common structural themes or secondary structures that appear repeatedly in different molecules
Outcomes would be measured with validated instruments: instrumental elasticity and firmness, corneometry and cutometry, standardized photography with blinded grading, and, most convincingly, dermal biopsies quantifying collagen density and organization before and after
A key tenet of this program is to ensure that breast-cancer activists play an integral role in policy and research decisions, given their unique and critical perspectives on the issues
